| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF134 SP3 ZNF668 ZNF594 ZNF182 ZNF605 ZNF789 ZNF517 ZNF732 ZNF337 ZNF652 MAZ ARX ZNF189 ZNF432 ZFHX2 ZNF571 ZNF350 ZNF84 ZNF275 ZNF782 ZNF317 RREB1 ZNF700 ZBTB3 ZNF623 ST18 ZNF692 | 5.45e-12 | 1412 | 88 | 28 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF134 SP3 ZNF668 ZNF594 ZNF182 ZNF605 ZNF613 ZNF789 ZNF517 ZNF732 ZNF337 ZNF652 MAZ ARX ZNF189 ZNF432 ZFHX2 ZNF571 ZNF350 ZNF84 ZNF275 ZNF782 ZNF317 RREB1 ZNF700 ZNF623 ST18 ZNF692 | 1.19e-11 | 1459 | 88 | 28 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF134 SP3 ZNF668 ZNF594 ZNF182 ZNF605 ZNF613 ZNF789 ZNF732 ZNF652 MAZ ARX ZNF189 ZNF432 ZFHX2 ZNF571 ZNF350 ZNF84 ZNF275 ZNF782 ZNF317 RREB1 ZNF623 ST18 ZNF692 | 7.75e-11 | 1244 | 88 | 25 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF134 SP3 ZNF668 ZNF594 ZNF182 ZNF605 ZNF613 ZNF789 ZNF732 ZNF652 MAZ ARX ZNF189 ZNF432 ZFHX2 ZNF571 ZNF350 ZNF84 ZNF275 ZNF782 ZNF317 RREB1 ZNF623 ST18 ZNF692 | 1.22e-10 | 1271 | 88 | 25 | GO:0000987 |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 1.64e-06 | 6 | 88 | 3 | GO:0034647 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 4.56e-06 | 8 | 88 | 3 | GO:0032453 | |
| GeneOntologyMolecularFunction | reelin receptor activity | 1.92e-05 | 2 | 88 | 2 | GO:0038025 | |
| GeneOntologyMolecularFunction | growth factor binding | 6.60e-05 | 156 | 88 | 6 | GO:0019838 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor activity | 1.15e-04 | 4 | 88 | 2 | GO:0030229 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 2.00e-04 | 26 | 88 | 3 | GO:0050431 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 2.50e-04 | 28 | 88 | 3 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 3.40e-04 | 31 | 88 | 3 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 3.74e-04 | 32 | 88 | 3 | GO:0140457 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 4.89e-04 | 35 | 88 | 3 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 4.89e-04 | 35 | 88 | 3 | GO:0071814 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 5.32e-04 | 320 | 88 | 7 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 5.94e-04 | 326 | 88 | 7 | GO:0001217 | |
| GeneOntologyMolecularFunction | demethylase activity | 9.61e-04 | 44 | 88 | 3 | GO:0032451 | |
| GeneOntologyMolecularFunction | integrin binding | 1.06e-03 | 175 | 88 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | sodium ion binding | 1.69e-03 | 14 | 88 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.21e-03 | 16 | 88 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 2.97e-03 | 65 | 88 | 3 | GO:0016706 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.44e-03 | 229 | 88 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 3.46e-03 | 20 | 88 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.82e-03 | 21 | 88 | 2 | GO:0030228 | |
| GeneOntologyCellularComponent | integrin alphav-beta6 complex | 1.83e-05 | 2 | 90 | 2 | GO:0034685 | |
| GeneOntologyCellularComponent | striated muscle myosin thick filament | 1.09e-04 | 4 | 90 | 2 | GO:0005863 | |
| GeneOntologyCellularComponent | integrin complex | 3.50e-04 | 32 | 90 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | fibrinogen complex | 5.05e-04 | 8 | 90 | 2 | GO:0005577 | |
| GeneOntologyCellularComponent | cell surface | VLDLR THBS1 HEG1 EGFR LMO7 PCSK6 ADAM29 ADGRE1 ITGAV ITGB2 ITGB6 IL6ST LRP8 | 9.17e-04 | 1111 | 90 | 13 | GO:0009986 |
| Domain | - | ZNF134 SP3 ZNF668 ZNF594 ZNF182 ZNF605 ZNF613 ZNF155 ZNF789 ZNF517 ZNF532 ZNF732 ZNF337 ZNF652 MAZ ZNF189 ZNF432 ZFHX2 ZNF571 ZNF350 ZNF84 ZNF782 ZNF317 RREB1 ZNF700 ZBTB3 ZNF623 ZNF692 | 5.32e-19 | 679 | 90 | 28 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF134 SP3 ZNF668 ZNF594 ZNF182 ZNF605 ZNF613 ZNF155 ZNF789 ZNF517 ZNF732 ZNF337 ZNF652 MAZ ZNF189 ZNF432 ZFHX2 ZNF571 ZNF350 ZNF84 ZNF275 ZNF782 ZNF317 RREB1 ZNF700 ZBTB3 ZNF623 ZNF692 | 9.10e-19 | 693 | 90 | 28 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF134 SP3 ZNF668 ZNF594 ZNF182 ZNF605 ZNF613 ZNF155 ZNF789 ZNF517 ZNF532 ZNF732 ZNF337 ZNF652 MAZ ZNF189 ZNF432 ZFHX2 ZNF571 ZNF350 ZNF84 ZNF782 ZNF317 RREB1 ZNF700 ZBTB3 ZNF623 ZNF692 | 9.45e-19 | 694 | 90 | 28 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF134 SP3 ZNF668 ZNF594 ZNF182 ZNF605 ZNF613 ZNF155 ZNF789 ZNF517 ZNF532 ZNF732 ZNF337 ZNF652 MAZ ZNF189 ZNF432 ZFHX2 ZNF571 ZNF350 ZNF84 ZNF275 ZNF782 ZNF317 RREB1 ZNF700 ZBTB3 ZNF623 ZNF692 | 1.50e-18 | 775 | 90 | 29 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF134 SP3 ZNF668 ZNF594 ZNF182 ZNF605 ZNF613 ZNF155 ZNF789 ZNF517 ZNF532 ZNF732 ZNF337 ZNF652 MAZ ZNF189 ZNF432 ZFHX2 ZNF571 ZNF350 ZNF84 ZNF275 ZNF782 ZNF317 RREB1 ZNF700 ZBTB3 ZNF623 ZNF692 | 1.61e-18 | 777 | 90 | 29 | PS00028 |
| Domain | Znf_C2H2 | ZNF134 SP3 ZNF668 ZNF594 ZNF182 ZNF605 ZNF613 ZNF155 ZNF789 ZNF517 ZNF532 ZNF732 ZNF337 ZNF652 MAZ ZNF189 ZNF432 ZFHX2 ZNF571 ZNF350 ZNF84 ZNF275 ZNF782 ZNF317 RREB1 ZNF700 ZBTB3 ZNF623 ZNF692 | 4.17e-18 | 805 | 90 | 29 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF134 SP3 ZNF668 ZNF594 ZNF182 ZNF605 ZNF613 ZNF155 ZNF789 ZNF517 ZNF532 ZNF732 ZNF337 ZNF652 MAZ ZNF189 ZNF432 ZFHX2 ZNF571 ZNF350 ZNF84 ZNF275 ZNF782 ZNF317 RREB1 ZNF700 ZBTB3 ZNF623 ZNF692 | 4.61e-18 | 808 | 90 | 29 | SM00355 |
| Domain | Znf_C2H2-like | ZNF134 SP3 ZNF668 ZNF594 ZNF182 ZNF605 ZNF613 ZNF155 ZNF789 ZNF517 ZNF532 ZNF732 ZNF337 ZNF652 MAZ ZNF189 ZNF432 ZFHX2 ZNF571 ZNF350 ZNF84 ZNF782 ZNF317 RREB1 ZNF700 ZBTB3 ZNF623 ZNF692 | 3.36e-17 | 796 | 90 | 28 | IPR015880 |
| Domain | KRAB | ZNF182 ZNF605 ZNF613 ZNF155 ZNF789 ZNF517 ZNF732 ZNF337 ZNF189 ZNF432 ZNF571 ZNF350 ZNF84 ZNF275 ZNF782 ZNF317 ZNF700 | 1.14e-12 | 358 | 90 | 17 | PS50805 |
| Domain | KRAB | ZNF182 ZNF605 ZNF613 ZNF155 ZNF789 ZNF517 ZNF732 ZNF337 ZNF189 ZNF432 ZNF571 ZNF350 ZNF84 ZNF275 ZNF782 ZNF317 ZNF700 | 1.14e-12 | 358 | 90 | 17 | PF01352 |
| Domain | KRAB | ZNF182 ZNF605 ZNF613 ZNF155 ZNF789 ZNF517 ZNF732 ZNF337 ZNF189 ZNF432 ZNF571 ZNF350 ZNF84 ZNF275 ZNF782 ZNF317 ZNF700 | 1.86e-12 | 369 | 90 | 17 | SM00349 |
| Domain | KRAB | ZNF182 ZNF605 ZNF613 ZNF155 ZNF789 ZNF517 ZNF732 ZNF337 ZNF189 ZNF432 ZNF571 ZNF350 ZNF84 ZNF275 ZNF782 ZNF317 ZNF700 | 1.94e-12 | 370 | 90 | 17 | IPR001909 |
| Domain | zf-C2H2_6 | ZNF668 ZNF182 ZNF605 ZNF613 ZNF155 ZNF789 ZNF532 ZNF732 ZNF652 ZNF432 ZNF571 ZNF84 ZNF782 ZNF317 RREB1 ZNF700 | 1.95e-12 | 314 | 90 | 16 | PF13912 |
| Domain | EGF-like_dom | 3.33e-07 | 249 | 90 | 10 | IPR000742 | |
| Domain | EGF_1 | 4.14e-07 | 255 | 90 | 10 | PS00022 | |
| Domain | Lys_sp_deMease-like_dom | 4.31e-07 | 4 | 90 | 3 | IPR013637 | |
| Domain | PLU-1 | 4.31e-07 | 4 | 90 | 3 | PF08429 | |
| Domain | EGF-like_CS | 5.13e-07 | 261 | 90 | 10 | IPR013032 | |
| Domain | EGF_2 | 5.89e-07 | 265 | 90 | 10 | PS01186 | |
| Domain | zf-C5HC2 | 1.07e-06 | 5 | 90 | 3 | PF02928 | |
| Domain | Znf_C5HC2 | 1.07e-06 | 5 | 90 | 3 | IPR004198 | |
| Domain | JmjN | 1.27e-05 | 10 | 90 | 3 | SM00545 | |
| Domain | JMJN | 1.27e-05 | 10 | 90 | 3 | PS51183 | |
| Domain | JmjN | 1.27e-05 | 10 | 90 | 3 | PF02375 | |
| Domain | JmjN | 1.27e-05 | 10 | 90 | 3 | IPR003349 | |
| Domain | EGF_3 | 1.78e-05 | 235 | 90 | 8 | PS50026 | |
| Domain | EGF_CA | 2.73e-05 | 122 | 90 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.99e-05 | 124 | 90 | 6 | IPR001881 | |
| Domain | - | 4.72e-05 | 15 | 90 | 3 | 1.10.150.60 | |
| Domain | BRIGHT | 4.72e-05 | 15 | 90 | 3 | SM00501 | |
| Domain | ARID_dom | 4.72e-05 | 15 | 90 | 3 | IPR001606 | |
| Domain | ARID | 4.72e-05 | 15 | 90 | 3 | PS51011 | |
| Domain | ARID | 4.72e-05 | 15 | 90 | 3 | PF01388 | |
| Domain | EGF_CA | 5.95e-05 | 86 | 90 | 5 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 1.06e-04 | 97 | 90 | 5 | IPR018097 | |
| Domain | Growth_fac_rcpt_ | 1.08e-04 | 156 | 90 | 6 | IPR009030 | |
| Domain | EGF_CA | 1.16e-04 | 99 | 90 | 5 | PS01187 | |
| Domain | ALBUMIN | 1.37e-04 | 4 | 90 | 2 | SM00103 | |
| Domain | Serum_albumin_N | 1.37e-04 | 4 | 90 | 2 | IPR014760 | |
| Domain | ALBUMIN_1 | 1.37e-04 | 4 | 90 | 2 | PS00212 | |
| Domain | Serum_albumin_CS | 1.37e-04 | 4 | 90 | 2 | IPR020857 | |
| Domain | Serum_albumin | 1.37e-04 | 4 | 90 | 2 | PF00273 | |
| Domain | ALBUMIN_2 | 1.37e-04 | 4 | 90 | 2 | PS51438 | |
| Domain | EGF | 1.41e-04 | 235 | 90 | 7 | SM00181 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.60e-04 | 106 | 90 | 5 | IPR000152 | |
| Domain | JmjC | 2.04e-04 | 24 | 90 | 3 | PF02373 | |
| Domain | Serum_albumin-like | 2.27e-04 | 5 | 90 | 2 | IPR020858 | |
| Domain | Integrin_dom | 2.30e-04 | 25 | 90 | 3 | IPR032695 | |
| Domain | Zinc_finger_PHD-type_CS | 2.73e-04 | 65 | 90 | 4 | IPR019786 | |
| Domain | - | 3.12e-04 | 449 | 90 | 9 | 3.30.40.10 | |
| Domain | Na_trans_cytopl | 3.40e-04 | 6 | 90 | 2 | PF11933 | |
| Domain | Integrin_bsu_cyt_dom | 3.40e-04 | 6 | 90 | 2 | IPR014836 | |
| Domain | GF_recep_IV | 3.40e-04 | 6 | 90 | 2 | PF14843 | |
| Domain | GF_recep_IV | 3.40e-04 | 6 | 90 | 2 | IPR032778 | |
| Domain | Integrin_b_cyt | 3.40e-04 | 6 | 90 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 3.40e-04 | 6 | 90 | 2 | PF08725 | |
| Domain | ALB/AFP/VDB | 3.40e-04 | 6 | 90 | 2 | IPR000264 | |
| Domain | Na_trans_cytopl | 3.40e-04 | 6 | 90 | 2 | IPR024583 | |
| Domain | Znf_RING/FYVE/PHD | 3.67e-04 | 459 | 90 | 9 | IPR013083 | |
| Domain | PHD | 4.72e-04 | 75 | 90 | 4 | PF00628 | |
| Domain | Integrin_bsu_tail | 4.75e-04 | 7 | 90 | 2 | IPR012896 | |
| Domain | Integrin_B_tail | 4.75e-04 | 7 | 90 | 2 | SM01242 | |
| Domain | Integrin_B_tail | 4.75e-04 | 7 | 90 | 2 | PF07965 | |
| Domain | JMJC | 4.85e-04 | 32 | 90 | 3 | PS51184 | |
| Domain | JmjC_dom | 4.85e-04 | 32 | 90 | 3 | IPR003347 | |
| Domain | JmjC | 5.32e-04 | 33 | 90 | 3 | SM00558 | |
| Domain | Znf_PHD-finger | 5.75e-04 | 79 | 90 | 4 | IPR019787 | |
| Domain | Integrin_beta | 6.31e-04 | 8 | 90 | 2 | PF00362 | |
| Domain | INB | 6.31e-04 | 8 | 90 | 2 | SM00187 | |
| Domain | Integrin_bsu_VWA | 6.31e-04 | 8 | 90 | 2 | IPR002369 | |
| Domain | Znf_FYVE_PHD | 7.25e-04 | 147 | 90 | 5 | IPR011011 | |
| Domain | Integrin_bsu | 8.09e-04 | 9 | 90 | 2 | IPR015812 | |
| Domain | Integin_beta_N | 8.09e-04 | 9 | 90 | 2 | IPR033760 | |
| Domain | INTEGRIN_BETA | 8.09e-04 | 9 | 90 | 2 | PS00243 | |
| Domain | PSI_integrin | 8.09e-04 | 9 | 90 | 2 | PF17205 | |
| Domain | - | 8.72e-04 | 39 | 90 | 3 | 2.120.10.30 | |
| Domain | PHD | 9.01e-04 | 89 | 90 | 4 | SM00249 | |
| Domain | LDLR_class-A_CS | 9.40e-04 | 40 | 90 | 3 | IPR023415 | |
| Domain | Znf_PHD | 9.79e-04 | 91 | 90 | 4 | IPR001965 | |
| Domain | Na_channel_asu | 1.01e-03 | 10 | 90 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.01e-03 | 10 | 90 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 1.01e-03 | 10 | 90 | 2 | PF06512 | |
| Domain | ZF_PHD_2 | 1.15e-03 | 95 | 90 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 1.19e-03 | 96 | 90 | 4 | PS01359 | |
| Domain | Ldl_recept_a | 1.33e-03 | 45 | 90 | 3 | PF00057 | |
| Domain | ASX_HYDROXYL | 1.39e-03 | 100 | 90 | 4 | PS00010 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.41e-03 | 46 | 90 | 3 | IPR011042 | |
| Domain | LDLRA_1 | 1.60e-03 | 48 | 90 | 3 | PS01209 | |
| Domain | LDLRA_2 | 1.70e-03 | 49 | 90 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.70e-03 | 49 | 90 | 3 | IPR002172 | |
| Domain | LDLa | 1.70e-03 | 49 | 90 | 3 | SM00192 | |
| Domain | Ldl_recept_b | 2.01e-03 | 14 | 90 | 2 | PF00058 | |
| Domain | LDLRB | 2.01e-03 | 14 | 90 | 2 | PS51120 | |
| Domain | LY | 2.31e-03 | 15 | 90 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.31e-03 | 15 | 90 | 2 | IPR000033 | |
| Domain | WAP | 2.64e-03 | 16 | 90 | 2 | SM00217 | |
| Domain | WAP | 2.64e-03 | 16 | 90 | 2 | PF00095 | |
| Domain | WAP | 2.98e-03 | 17 | 90 | 2 | PS51390 | |
| Domain | - | 2.98e-03 | 17 | 90 | 2 | 4.10.75.10 | |
| Domain | EGF | 3.23e-03 | 126 | 90 | 4 | PF00008 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | KDM5B ZNF668 THBS1 ZNF605 ZNF613 ZNF155 ZNF517 EGFR ZNF732 ZNF337 ZNF189 ZNF432 PPP1R13B ZNF571 ZNF350 ZNF782 ZNF317 ZNF700 ZNF692 | 1.23e-05 | 1387 | 66 | 19 | M734 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.76e-05 | 76 | 66 | 5 | MM14867 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 4.29e-05 | 42 | 66 | 4 | M174 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.74e-05 | 85 | 66 | 5 | M16441 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 2.36e-04 | 26 | 66 | 3 | M47 | |
| Pathway | BIOCARTA_EEA1_PATHWAY | 3.20e-04 | 6 | 66 | 2 | MM1577 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 3.28e-04 | 29 | 66 | 3 | MM14934 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 4.47e-04 | 7 | 66 | 2 | MM1566 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 4.47e-04 | 7 | 66 | 2 | M22049 | |
| Pathway | BIOCARTA_EEA1_PATHWAY | 4.47e-04 | 7 | 66 | 2 | M22064 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 6.38e-04 | 84 | 66 | 4 | M7098 | |
| Pubmed | Novel JARID1C/SMCX mutations in patients with X-linked mental retardation. | 6.69e-08 | 4 | 90 | 3 | 16541399 | |
| Pubmed | 6.69e-08 | 4 | 90 | 3 | 17320160 | ||
| Pubmed | Thrombospondin-1 binds to ApoER2 and VLDL receptor and functions in postnatal neuronal migration. | 1.67e-07 | 5 | 90 | 3 | 18946489 | |
| Pubmed | VLDLR KDM5B THBS1 ZNF605 PSAP ZNF532 LMO7 TRIM32 ATP13A1 PCSK6 ZNF189 OSBPL8 ZNF350 ZNF84 ST18 MTMR10 | 1.80e-07 | 1285 | 90 | 16 | 35914814 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 2.64e-07 | 101 | 90 | 6 | 23382219 | |
| Pubmed | 3.66e-07 | 257 | 90 | 8 | 16335952 | ||
| Pubmed | 3.90e-07 | 57 | 90 | 5 | 18022353 | ||
| Pubmed | 3.62e-06 | 12 | 90 | 3 | 19693543 | ||
| Pubmed | 4.70e-06 | 13 | 90 | 3 | 24619213 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 19549907 | ||
| Pubmed | Study on the effect of Integrin αVβ6 on proliferation and apoptosis of cervical cancer cells. | 6.62e-06 | 2 | 90 | 2 | 28682441 | |
| Pubmed | Integrin alpha v beta 6 is an RGD-dependent receptor for coxsackievirus A9. | 6.62e-06 | 2 | 90 | 2 | 15194773 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 22232213 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 28730778 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20838674 | ||
| Pubmed | Integrin alphaVbeta6 is a high-affinity receptor for coxsackievirus A9. | 6.62e-06 | 2 | 90 | 2 | 19088289 | |
| Pubmed | Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx. | 6.62e-06 | 2 | 90 | 2 | 10441747 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 34979108 | ||
| Pubmed | Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus. | 6.62e-06 | 2 | 90 | 2 | 16416087 | |
| Pubmed | Stable Peptides Instead of Stapled Peptides: Highly Potent αvβ6-Selective Integrin Ligands. | 6.62e-06 | 2 | 90 | 2 | 26663660 | |
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 6.62e-06 | 2 | 90 | 2 | 24990319 | |
| Pubmed | The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice. | 6.62e-06 | 2 | 90 | 2 | 17261317 | |
| Pubmed | The UIM domain of Hrs couples receptor sorting to vesicle formation. | 6.62e-06 | 2 | 90 | 2 | 12953068 | |
| Pubmed | αvβ6 integrin may be a potential prognostic biomarker in interstitial lung disease. | 6.62e-06 | 2 | 90 | 2 | 25745053 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 18294287 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 26371120 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 32081420 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 21601501 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 30355650 | ||
| Pubmed | Integrin alpha v beta 6 contributes to maintaining corneal epithelial barrier function. | 6.62e-06 | 2 | 90 | 2 | 23412966 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 27690330 | ||
| Pubmed | Hypoxia increases reepithelialization via an alphavbeta6-dependent pathway. | 6.62e-06 | 2 | 90 | 2 | 15828940 | |
| Pubmed | Integrin alphavbeta6 is involved in measles protein-induced airway immune suppression. | 6.62e-06 | 2 | 90 | 2 | 22579114 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 30873003 | ||
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 6.62e-06 | 2 | 90 | 2 | 23965409 | |
| Pubmed | Rules of engagement between αvβ6 integrin and foot-and-mouth disease virus. | 6.62e-06 | 2 | 90 | 2 | 28534487 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 33069505 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 7524912 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 24150233 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 24175614 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 32450701 | ||
| Pubmed | Overexpression of the alphavbeta6 integrin in endometrial cancer. | 6.62e-06 | 2 | 90 | 2 | 18698261 | |
| Pubmed | Critical role for αvβ6 integrin in enamel biomineralization. | 6.62e-06 | 2 | 90 | 2 | 23264742 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 35468265 | ||
| Pubmed | Phosphorylation of Hrs downstream of the epidermal growth factor receptor. | 6.62e-06 | 2 | 90 | 2 | 12180964 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 29798908 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 18301736 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 31243731 | ||
| Pubmed | Role of integrin alphav beta6 in acute lung injury induced by Pseudomonas aeruginosa. | 6.62e-06 | 2 | 90 | 2 | 18378634 | |
| Pubmed | Characterization of integrin beta6 and thrombospondin-1 double-null mice. | 6.62e-06 | 2 | 90 | 2 | 15963261 | |
| Pubmed | Identification of functional segments within the beta2I-domain of integrin alphaMbeta2. | 6.62e-06 | 2 | 90 | 2 | 12324470 | |
| Pubmed | Analysis of mutation rates in the SMCY/SMCX genes shows that mammalian evolution is male driven. | 6.62e-06 | 2 | 90 | 2 | 9060413 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 34929721 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 19581582 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 18221819 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 38844455 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 23331428 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 16301625 | ||
| Pubmed | 8.13e-06 | 49 | 90 | 4 | 34368113 | ||
| Pubmed | 1.33e-05 | 18 | 90 | 3 | 10827173 | ||
| Pubmed | Reelin together with ApoER2 regulates interneuron migration in the olfactory bulb. | 1.98e-05 | 3 | 90 | 2 | 23209795 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 20427281 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 18032585 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 33895391 | ||
| Pubmed | CIN85 regulates ubiquitination and degradative endosomal sorting of the EGF receptor. | 1.98e-05 | 3 | 90 | 2 | 21635887 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 15950758 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 23859570 | ||
| Pubmed | Disabled 1 Is Part of a Signaling Pathway Activated by Epidermal Growth Factor Receptor. | 1.98e-05 | 3 | 90 | 2 | 33572344 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 29934325 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 18778775 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 27816501 | ||
| Pubmed | The integrin alphaVbeta6 binds and activates latent TGFbeta3. | 1.98e-05 | 3 | 90 | 2 | 11821050 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 8666675 | ||
| Pubmed | Integrin alpha(v)beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells. | 1.98e-05 | 3 | 90 | 2 | 12177807 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 28123028 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 11920707 | ||
| Pubmed | Linkage of open eyelids with linkage group VII of the mouse. | 1.98e-05 | 3 | 90 | 2 | 5690495 | |
| Pubmed | Dissociation of HSV gL from gH by αvβ6- or αvβ8-integrin promotes gH activation and virus entry. | 1.98e-05 | 3 | 90 | 2 | 26157134 | |
| Pubmed | Integrins as triggers of Epstein-Barr virus fusion and epithelial cell infection. | 1.98e-05 | 3 | 90 | 2 | 21178476 | |
| Pubmed | Interaction of alphaVbeta3 and alphaVbeta6 integrins with human parechovirus 1. | 1.98e-05 | 3 | 90 | 2 | 20554778 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 38230606 | ||
| Pubmed | Binding of purified Reelin to ApoER2 and VLDLR mediates tyrosine phosphorylation of Disabled-1. | 1.98e-05 | 3 | 90 | 2 | 12670700 | |
| Pubmed | The Reelin receptors ApoER2 and VLDLR are direct target genes of HIC1 (Hypermethylated In Cancer 1). | 1.98e-05 | 3 | 90 | 2 | 24076391 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 22170052 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 28408295 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 18349127 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 15212941 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 29339538 | ||
| Pubmed | Functional importance of covalent homodimer of reelin protein linked via its central region. | 1.98e-05 | 3 | 90 | 2 | 21844191 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 12610651 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 22672426 | ||
| Pubmed | An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin. | 1.98e-05 | 3 | 90 | 2 | 2478219 | |
| Pubmed | D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR. | 1.98e-05 | 3 | 90 | 2 | 29184982 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 23083738 | ||
| Pubmed | Identification of a mouse male-specific transplantation antigen, H-Y. | 1.98e-05 | 3 | 90 | 2 | 7544442 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 18784617 | ||
| Pubmed | Thrombospondin 1 and Reelin act through Vldlr to regulate cardiac growth and repair. | 1.98e-05 | 3 | 90 | 2 | 38147128 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 12782602 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 17544618 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 21531776 | ||
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF134 SP3 ZNF668 ZNF594 ZNF182 ZNF605 ZNF613 ZNF155 ZNF789 ZNF517 ZNF532 ZNF732 ZNF337 ZNF652 MAZ ZNF189 ZNF432 ZFHX2 ZNF571 ZNF350 ZNF84 ZNF275 ZNF782 ZNF317 RREB1 ZNF700 ZBTB3 ZNF623 ZNF692 | 6.84e-21 | 718 | 79 | 29 | 28 |
| GeneFamily | AT-rich interaction domain containing | 3.52e-05 | 15 | 79 | 3 | 418 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.52e-04 | 24 | 79 | 3 | 485 | |
| GeneFamily | PHD finger proteins | 6.49e-04 | 90 | 79 | 4 | 88 | |
| GeneFamily | CD molecules|Integrin beta subunits | 6.65e-04 | 9 | 79 | 2 | 1159 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 6.65e-04 | 9 | 79 | 2 | 1203 | |
| GeneFamily | Low density lipoprotein receptors | 1.43e-03 | 13 | 79 | 2 | 634 | |
| GeneFamily | WAP four-disulfide core domain containing|Fibronectin type III domain containing | 2.76e-03 | 18 | 79 | 2 | 361 | |
| GeneFamily | Ring finger proteins | 7.09e-03 | 275 | 79 | 5 | 58 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 9.66e-03 | 34 | 79 | 2 | 487 | |
| GeneFamily | Complement system|Sushi domain containing | 1.08e-02 | 36 | 79 | 2 | 492 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_TFH-like|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.58e-06 | 192 | 90 | 6 | 0f9cae41bb9bc9366efe9eb48e26b3e80c642879 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.58e-06 | 192 | 90 | 6 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-05 | 165 | 90 | 5 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-05 | 165 | 90 | 5 | 507c89ece0a336b8e9c65b79889a714e17ddca27 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-05 | 165 | 90 | 5 | 39a25be081a5d59c7cf107a997d352793d5025fb | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-05 | 165 | 90 | 5 | 1890f9c33b0c5b381d57f97042da2610a093a6de | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.26e-05 | 167 | 90 | 5 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 2.68e-05 | 173 | 90 | 5 | 62e0c18cfed9645e34a9d7029c94a8554f773714 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 177 | 90 | 5 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 177 | 90 | 5 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-05 | 89 | 90 | 4 | d8832dbe69d3490ceaa05ccc99d7c81707803925 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 3.50e-05 | 183 | 90 | 5 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-05 | 183 | 90 | 5 | d26c7b79895de28961b8d68351f28d4bb531c75c | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.59e-05 | 184 | 90 | 5 | d7f348aa8901d819c68da20728b9238407bcdca9 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 186 | 90 | 5 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.78e-05 | 186 | 90 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-05 | 187 | 90 | 5 | 00930e407beaa337f72533a69f32d150faad8b9a | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 188 | 90 | 5 | e99e3765b48392c987cf0c5ccbded0655637d7b7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-05 | 188 | 90 | 5 | 2b8d70f761eda5509f21845a87cdb3602a639dd7 | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.19e-05 | 190 | 90 | 5 | d2afa08ad868acc6fce308ec21b0bf93591d4010 | |
| ToppCell | facs-Thymus-Epithelium-24m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | eec14997d2bfc7e6b5a601afc43a147f6b96d668 | |
| ToppCell | facs-Thymus-Epithelium-24m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | 1730ec5dc1cfd2f0cba7e21555641c7bce97e09d | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | facs-Thymus-Epithelium-24m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | 4b77abc68bd72c64e7062f9527fe9d9605289ceb | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.29e-05 | 191 | 90 | 5 | c9f3bdb5c0a90268cab24a0fe4c3a8290fcedeb8 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.40e-05 | 192 | 90 | 5 | b86476037ddf8904c1d8a6b3763af7242c031cf3 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 192 | 90 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.51e-05 | 193 | 90 | 5 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 193 | 90 | 5 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.62e-05 | 194 | 90 | 5 | ce0486ce43748ffe486f08fdddd1f6acbfcc6b0e | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.62e-05 | 194 | 90 | 5 | b133d3d198360269cc449a75d34c29be377d91e0 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-05 | 195 | 90 | 5 | 01da7115e38c280fb0baff2032b62bdb609bad5e | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.74e-05 | 195 | 90 | 5 | fc43cd295f2cc3f6e9442232e028944f011c82cc | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.97e-05 | 197 | 90 | 5 | e2c53742c7d8d1b63d93843f82330b9e20f1faa6 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.97e-05 | 197 | 90 | 5 | 9838dbd1623babf8de7e9126a28fe5d3666bce42 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.97e-05 | 197 | 90 | 5 | f807d8cd377ee58c02be7f71b39cd227f6b4f5df | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-05 | 198 | 90 | 5 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-05 | 199 | 90 | 5 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.22e-05 | 199 | 90 | 5 | e225c1bfc55947c30e7948be851daea04975efa5 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-05 | 199 | 90 | 5 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-05 | 199 | 90 | 5 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-05 | 199 | 90 | 5 | e12cea071e46436835cc22fe7badcbe878a1305b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-05 | 199 | 90 | 5 | 2ff5007b971c6fca9a9ef433e257739f0322a2a5 | |
| ToppCell | control-unassigned|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.22e-05 | 199 | 90 | 5 | 5db7c8089172ac8e796613b3cef618d87007a0ab | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.65e-05 | 118 | 90 | 4 | 8d96a4879b28979fa04fbaeffa271a6b9ecbe867 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 128 | 90 | 4 | 003e133469899a9abe3a7f6d7f580583b281f412 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 139 | 90 | 4 | 82bf5ba69a907fbd9b4e2b2dd1dd27b8c4c75f25 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 139 | 90 | 4 | fc9ac09c2106e88104a52575832d71d17765eec8 | |
| ToppCell | facs-Liver-Hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 139 | 90 | 4 | fc4b39ac9a10cf0acacfebbc4295edf324d930d5 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 139 | 90 | 4 | 4ddfbc36a0560fb70594627178bff652ab1ea3e9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.86e-04 | 140 | 90 | 4 | 276b3fa924176426efb31112ed4d355407f0b218 | |
| ToppCell | facs-Skin-Anagen-3m-Myeloid|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 143 | 90 | 4 | 250f60f06f262f00acd14b09b3ef90dbb9759336 | |
| ToppCell | facs-Skin-Anagen-3m-Myeloid-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 143 | 90 | 4 | 0c7c0d7ca040e87412295672cd1f065c0e941391 | |
| ToppCell | facs-Skin-Anagen-3m-Myeloid-macrophage|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 143 | 90 | 4 | 27f4896276342758651fe7a80d7408ac5e1be9c0 | |
| ToppCell | Epithelial-B_(AT1-AT2-progenitors)|World / shred on cell class and cell subclass (v4) | 2.19e-04 | 146 | 90 | 4 | 4511916904c1fac252cb68e871b782207f8137b3 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.62e-04 | 153 | 90 | 4 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.62e-04 | 153 | 90 | 4 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | droplet-Bladder-nan-24m-Hematologic-macrophage|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 158 | 90 | 4 | 4a9d4706876f6e86fc5d63ad6dc7df1b4a5cfd9e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.03e-04 | 159 | 90 | 4 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-04 | 161 | 90 | 4 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-04 | 161 | 90 | 4 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-04 | 161 | 90 | 4 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.25e-04 | 162 | 90 | 4 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | COVID-CD8-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 3.25e-04 | 162 | 90 | 4 | 22b2a32217d357146c117e618813d451510a1801 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-04 | 163 | 90 | 4 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-04 | 163 | 90 | 4 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-04 | 164 | 90 | 4 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-04 | 164 | 90 | 4 | f88871d3b9307112eb7ced4c629f5704326ecae8 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-04 | 164 | 90 | 4 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-04 | 164 | 90 | 4 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-04 | 164 | 90 | 4 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-myeloid_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-04 | 165 | 90 | 4 | bfe330751d34813af7540765b490406078c40da7 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-04 | 165 | 90 | 4 | 8bdeacbb47948fabae2575689f811a9fad47f779 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.73e-04 | 168 | 90 | 4 | 8f0c4dfad9f6fed9dcc31795abfe77758ceb46a1 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.82e-04 | 169 | 90 | 4 | f077e39e41fffe7672541f5b72b80faaf56c597c | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 169 | 90 | 4 | 0f5e737b265ba333275a0cd289dab029a1542075 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.90e-04 | 170 | 90 | 4 | 3e52d40b0c36ab5b627a2dad025248901af8a320 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.90e-04 | 170 | 90 | 4 | 35e3945d8a540a3e2cec1b559316265aaad023d1 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.90e-04 | 170 | 90 | 4 | 0ea625abaa25bab93b70b7000e8f90d5c0f9a0fb | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-04 | 170 | 90 | 4 | 29deb285d5a82c0abcc108012ca42f4b4b4d9e19 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-04 | 170 | 90 | 4 | dc35d66a9a9fe6cdd7f4ec0fe7efa49d02f2b5b2 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.90e-04 | 170 | 90 | 4 | 0b5ddc7d452db0a389927a367914f7d257703f7e | |
| ToppCell | E12.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.99e-04 | 171 | 90 | 4 | a4d6b0f57eead11b01153688b06b2a45a3b488f2 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-04 | 172 | 90 | 4 | d65ffff3e341af34a043a0d802d7ba4b69de36e9 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-04 | 172 | 90 | 4 | 5f18c3f8eb8b7928901eede44c9b84b3c5efa1a9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.17e-04 | 173 | 90 | 4 | e4d9a9a781acc531bc81c3fcee24d637e805c8e1 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.17e-04 | 173 | 90 | 4 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.26e-04 | 174 | 90 | 4 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.26e-04 | 174 | 90 | 4 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.35e-04 | 175 | 90 | 4 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.35e-04 | 175 | 90 | 4 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.35e-04 | 175 | 90 | 4 | 69ed3c7c45df6bef70f5f2ff003531160bf3b32b | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-04 | 175 | 90 | 4 | 92a4a3fd323ee8360edd659f9e16dfddc8788e2f | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 176 | 90 | 4 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | AT1-AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.45e-04 | 176 | 90 | 4 | f86832cfeff5b3cfffe4455c1b96a1420d48ba1e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.45e-04 | 176 | 90 | 4 | fb718a6b07aa5d56600263280afa530bcb63db42 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 176 | 90 | 4 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 4.45e-04 | 176 | 90 | 4 | 7a74217b7fa1032b918f00a3972dff5fab74671a | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.54e-04 | 177 | 90 | 4 | 8dfadd9852e0c256363471a7cfe6af120c8c51e0 | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.54e-04 | 177 | 90 | 4 | 767b2af5f224d100b22bed32f86cec1cd17e8711 | |
| Computational | Genes in the cancer module 275. | 8.36e-05 | 16 | 59 | 3 | MODULE_275 | |
| Drug | Indoprofen [31842-01-0]; Up 200; 14.2uM; PC3; HT_HG-U133A | 8.74e-08 | 197 | 90 | 9 | 4249_UP | |
| Drug | Carbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 1.15e-06 | 197 | 90 | 8 | 3299_DN | |
| Drug | Sulfaphenazole [526-08-9]; Up 200; 12.8uM; HL60; HT_HG-U133A | 1.20e-06 | 198 | 90 | 8 | 1836_UP | |
| Drug | Rgd Peptide | 4.85e-06 | 239 | 90 | 8 | CID000104802 | |
| Drug | Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.12e-05 | 192 | 90 | 7 | 3375_DN | |
| Drug | Methazolamide [554-57-4]; Up 200; 17uM; MCF7; HT_HG-U133A | 1.16e-05 | 193 | 90 | 7 | 3474_UP | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A | 1.20e-05 | 194 | 90 | 7 | 4331_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.20e-05 | 194 | 90 | 7 | 3419_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 1.24e-05 | 195 | 90 | 7 | 3217_UP | |
| Drug | Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.29e-05 | 196 | 90 | 7 | 7337_UP | |
| Drug | Thyroxine (L) [51-48-9]; Down 200; 5.2uM; HL60; HT_HG-U133A | 1.29e-05 | 196 | 90 | 7 | 1312_DN | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; HL60; HT_HG-U133A | 1.33e-05 | 197 | 90 | 7 | 1853_UP | |
| Drug | Rolitetracycline [751-97-3]; Up 200; 7.6uM; PC3; HT_HG-U133A | 1.42e-05 | 199 | 90 | 7 | 6731_UP | |
| Drug | AB-4 | 5.53e-05 | 19 | 90 | 3 | CID001367558 | |
| Drug | Ellipticine [519-23-3]; Down 200; 16.2uM; PC3; HT_HG-U133A | 8.07e-05 | 180 | 90 | 6 | 5779_DN | |
| Drug | Mitoxantrone dihydrochloride [70476-82-3]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 8.84e-05 | 183 | 90 | 6 | 3232_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.09e-04 | 190 | 90 | 6 | 2869_DN | |
| Drug | geldanamycin | 1.12e-04 | 371 | 90 | 8 | ctd:C001277 | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.15e-04 | 192 | 90 | 6 | 4104_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | 1.15e-04 | 192 | 90 | 6 | 4274_DN | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.18e-04 | 193 | 90 | 6 | 4343_DN | |
| Drug | Clotrimazole [23593-75-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.18e-04 | 193 | 90 | 6 | 6207_UP | |
| Drug | Spurr resin | 1.21e-04 | 64 | 90 | 4 | CID006449895 | |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.22e-04 | 194 | 90 | 6 | 2792_DN | |
| Drug | Cyclizine hydrochloride [303-25-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.22e-04 | 194 | 90 | 6 | 2880_DN | |
| Drug | Nadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.22e-04 | 194 | 90 | 6 | 4139_UP | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A | 1.25e-04 | 195 | 90 | 6 | 3634_UP | |
| Drug | Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.29e-04 | 196 | 90 | 6 | 6506_DN | |
| Drug | Moricizine hydrochloride [31883-05-3]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.29e-04 | 196 | 90 | 6 | 7297_DN | |
| Drug | Epirizole [18694-40-1]; Up 200; 17uM; MCF7; HT_HG-U133A | 1.29e-04 | 196 | 90 | 6 | 1681_UP | |
| Drug | Iopanoic acid [96-83-3]; Up 200; 7uM; PC3; HT_HG-U133A | 1.32e-04 | 197 | 90 | 6 | 6348_UP | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 1.32e-04 | 197 | 90 | 6 | 7500_UP | |
| Drug | Aminocaproic acid [60-32-2]; Down 200; 30.4uM; HL60; HT_HG-U133A | 1.32e-04 | 197 | 90 | 6 | 3122_DN | |
| Drug | Papaverine hydrochloride [61-25-6]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 197 | 90 | 6 | 2747_DN | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.36e-04 | 198 | 90 | 6 | 4773_DN | |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.36e-04 | 198 | 90 | 6 | 4785_DN | |
| Drug | Cefazolin sodium salt [27164-46-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.36e-04 | 198 | 90 | 6 | 3426_DN | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.36e-04 | 198 | 90 | 6 | 4979_DN | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.36e-04 | 198 | 90 | 6 | 4792_DN | |
| Drug | Sulfisoxazole [127-69-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.36e-04 | 198 | 90 | 6 | 5622_DN | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.40e-04 | 199 | 90 | 6 | 3541_UP | |
| Drug | Lorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.40e-04 | 199 | 90 | 6 | 6456_UP | |
| Drug | Chlormezanone [80-77-3]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.40e-04 | 199 | 90 | 6 | 5697_UP | |
| Drug | palladium | 1.53e-04 | 68 | 90 | 4 | CID000023938 | |
| Drug | AC1NE3ZI | 1.62e-04 | 69 | 90 | 4 | CID004636205 | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 8.88e-08 | 4 | 84 | 3 | DOID:0060809 (implicated_via_orthology) | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.21e-05 | 16 | 84 | 3 | DOID:0050888 (implicated_via_orthology) | |
| Disease | executive function measurement, cognitive function measurement | 4.79e-05 | 4 | 84 | 2 | EFO_0008354, EFO_0009332 | |
| Disease | intellectual disability (implicated_via_orthology) | 6.37e-05 | 75 | 84 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.55e-05 | 152 | 84 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1 | 1.19e-04 | 6 | 84 | 2 | C3463992 | |
| Disease | calcineurin subunit B type 1 measurement | 1.67e-04 | 7 | 84 | 2 | EFO_0020215 | |
| Disease | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 2.22e-04 | 8 | 84 | 2 | C0796250 | |
| Disease | bipolar II disorder | 2.22e-04 | 8 | 84 | 2 | EFO_0009964 | |
| Disease | X-linked infantile spasms | 2.22e-04 | 8 | 84 | 2 | C4552072 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.55e-04 | 10 | 84 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.55e-04 | 10 | 84 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | dementia (is_implicated_in) | 5.19e-04 | 12 | 84 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 5.19e-04 | 12 | 84 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | cutaneous melanoma, hair color | 7.46e-04 | 62 | 84 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | hemorrhoid | 8.38e-04 | 147 | 84 | 4 | EFO_0009552 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 9.36e-04 | 16 | 84 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | Dermatitis | 9.36e-04 | 16 | 84 | 2 | C0011603 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 9.36e-04 | 16 | 84 | 2 | C0393706 | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 1.06e-03 | 17 | 84 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | muscular dystrophy (is_implicated_in) | 1.06e-03 | 17 | 84 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | colorectal cancer (is_marker_for) | 1.07e-03 | 157 | 84 | 4 | DOID:9256 (is_marker_for) | |
| Disease | Intellectual Disability | 1.76e-03 | 447 | 84 | 6 | C3714756 | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.78e-03 | 22 | 84 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | corpus collosum mid-posterior volume measurement | 2.30e-03 | 25 | 84 | 2 | EFO_0010300 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.36e-03 | 195 | 84 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 2.40e-03 | 93 | 84 | 3 | C1535926 | |
| Disease | Heart valve disease | 2.49e-03 | 26 | 84 | 2 | C0018824 | |
| Disease | inflammatory biomarker measurement | 2.49e-03 | 26 | 84 | 2 | EFO_0004872 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEEVKPCSEKRCPAF | 516 | O60241 | |
| SGKVCRKEVNECDLP | 451 | Q9UKF5 | |
| VVDKCCKAESPEVCF | 576 | P43652 | |
| IPFAGKVEVCCFDKT | 521 | Q9HD20 | |
| FCSACKDKSVRIIDP | 191 | Q9BR76 | |
| KDRCESCSGAKVIRE | 191 | Q8WW22 | |
| TTCRDVVEFCKEPGE | 26 | Q96KQ4 | |
| PTGLSKEDFAEVCKR | 91 | Q9BU76 | |
| CKEIKDECPSAFDGL | 41 | Q8WWA0 | |
| CIGCKNFEESPERKT | 626 | Q6MZP7 | |
| FRFDESGPESAKKVC | 146 | Q9NXD2 | |
| KNERTEEAECRCKPG | 701 | Q17R60 | |
| PDDERQCIKCKTTCF | 691 | Q9BY66 | |
| PEKCTVCKEGFSLAR | 811 | P29122 | |
| AREECVDKCKLAGAT | 641 | P18564 | |
| RGTCTDAKTIDCKPE | 8181 | Q7Z5P9 | |
| ASRIAKVCAEEKCPT | 2126 | O94915 | |
| RKDKDSGGESPCVSC | 1276 | Q8IZD2 | |
| KPEDRESLKSACVVC | 291 | Q969V5 | |
| KRCASKVPRDCLGEV | 311 | O94806 | |
| CVFERTCPSKEKSNS | 611 | Q8WWI1 | |
| STERPFKCEKCEAAF | 361 | P56270 | |
| PDDERQCVKCKTTCF | 686 | Q9UGL1 | |
| FRAGSLCKRKSPECD | 1171 | Q9ULI3 | |
| AKERGPSAAEVFKCV | 251 | Q8WVZ9 | |
| CEIIERPSKKDGFCF | 196 | Q9BZF1 | |
| PVKGRTCKERDSEGC | 656 | P05107 | |
| KGVSERESCNDPCKE | 746 | Q9BXP8 | |
| ICEPFERKTSIVDCG | 1166 | Q9BXP8 | |
| CRKFRDEATCKDTCP | 251 | P00533 | |
| DCKAKRDTPTSCTVD | 171 | P40189 | |
| SDCDPCIEKQSKVRS | 91 | P13671 | |
| CGEDNVCKPKLEVSV | 626 | P06756 | |
| ICKLPKDEGTCRDFI | 3111 | P12111 | |
| KSCKGVPVSEAECTA | 66 | Q969Z3 | |
| QEEGCSERPECKSKS | 6 | Q96QS3 | |
| KDVCPVRLESRGKCE | 36 | Q14314 | |
| KDKSDEADCPLGTCR | 286 | Q14114 | |
| CFEVAAQRSPDKKTC | 126 | Q9H488 | |
| CSAVRPKFVTCDAEG | 511 | Q13049 | |
| ICEGFENPCKDKIDT | 1776 | O60522 | |
| GKKDCCFEISAPDKR | 181 | O75563 | |
| GTSEKDRPCETCGKN | 61 | O14802 | |
| EDLKPEACFTEGCIK | 1161 | Q9NY46 | |
| EPEACFTEGCVQRFK | 1176 | P35498 | |
| IKTEGDKFIPCENRC | 236 | O60284 | |
| FKDPGVRCKDIDECS | 71 | Q14246 | |
| KEETPKFCSQCGERL | 11 | Q63HN8 | |
| EKPFLCIECGKSFSR | 341 | O75820 | |
| SPDGAVSDRKCKVCA | 1256 | Q9HCE3 | |
| KTELCRPFEENGACK | 116 | Q07352 | |
| CGFKCVIPVKELEEG | 66 | Q8WWY7 | |
| PEVKSCDSFVCAEVG | 121 | Q9H0M5 | |
| GEARETKACKKDACP | 476 | P07996 | |
| ECPECGKAFREKSTV | 291 | P17025 | |
| EKPPQFVCRECKETF | 511 | Q96K58 | |
| TAATDKPFKCTVCRV | 1241 | Q9C0A1 | |
| GRKPFECKECSAAFA | 786 | Q92766 | |
| TGEKKFVCPECSKRF | 676 | Q02447 | |
| PKFGIEKEVRVCEPC | 201 | O14964 | |
| PGTAECCTKEGLERK | 106 | P02774 | |
| PKEICALVGFCDEVK | 261 | P07602 | |
| CRIFCSKKTGEEILP | 521 | Q86X10 | |
| KPDCKVGRITTTEDF | 2491 | Q9BYW2 | |
| EKPFACTECGKAFRR | 421 | Q6ZMY9 | |
| PFECRECGKAFSRKS | 346 | P51523 | |
| EKPFECSECGKAFST | 371 | Q9GZX5 | |
| RFSGVDKPFCSEVCK | 486 | O95789 | |
| DKPFCSEVCKFLSAR | 491 | O95789 | |
| GEKPFVCSECRKAFS | 621 | O94892 | |
| AREKCVGSVKLENPC | 536 | Q6PF04 | |
| TGEKPFRCDTCDKSF | 311 | Q12901 | |
| CKECGKTQSELRPSE | 791 | Q96JF6 | |
| ECPVCFEKLDVTAKV | 11 | Q8TEC5 | |
| CPECGKAFSEKSRLR | 396 | Q6ZMW2 | |
| KPFTCEECGKIITSS | 276 | B4DXR9 | |
| RERPFECKECGKGFS | 231 | O75123 | |
| EKETLTCEKCPRVFN | 241 | Q9Y2D9 | |
| REAKPFECEECGKRF | 176 | Q9NSD4 | |
| EKPFDCEECGRSFKV | 206 | Q9NSD4 | |
| TSFAEEVEKPTKCGC | 1516 | O75093 | |
| PFECKECGKAFIRVA | 446 | Q7Z3V5 | |
| GEKPFECSECRKAFA | 501 | Q86T29 | |
| ECKECGKSFGDLVSR | 391 | Q96PQ6 | |
| PFVCSKCGKDFIRTS | 371 | P52741 | |
| EFCGKRFEKPDSVAA | 451 | Q9BU19 | |
| KCKEFVDSCRLTFPT | 131 | Q5FWF6 | |
| EKPFVCKDCERSFSQ | 401 | Q9Y3M9 | |
| TKCDEIDGKPVLREC | 351 | Q5GH70 | |
| PGKFKCRSGECIDIS | 321 | P98155 | |
| VCKCKDRCEKEPSFT | 131 | Q8TEU8 | |
| VFTEDVPTCKTCGKT | 466 | Q9H5J0 | |
| PDDERQCIKCKTTCF | 701 | P41229 | |
| CVVGGEKCSTELFVK | 436 | Q14896 |